Table 3. Long-term antibiotic prophylaxis of recurring urinary tract infection (after [31]).
| Substance | Dosage |
Anticipated UTI rate per patient year |
Sensitivity |
Collateral damage |
Safety/adverse drug reactions (ADR) |
| Continuous long-term prophylaxis | |||||
| Cotrimoxazole | 40/200 mg 1 × daily | 0–0.2 | +(+) | ++ | ++ |
| Cotrimoxazole | 40/200 mg 3 × weekly | 0.1 | +(+) | ++ | ++ |
| Trimethoprim | 100 mg 1 × daily*1 | 0–1.5 | +(+) | ++ | +++ |
| Nitrofurantoin | 50 mg 1 × daily | 0–0.6 | +++ | +++ | ++ |
| Nitrofurantoin | 100 mg 1 × daily*2 | 0–0.7 | +++ | +++ | ++ |
| Cefaclor | 250 mg 1 × daily*3 | 0.0 | n.d. | + | +++ |
| Cefaclor | 125 mg 1 × daily*3 | 0.1 | n.d. | + | +++ |
| Norfloxacin | 200 mg 1 × daily*3 | 0.0 | ++ | + | ++ |
| Ciprofloxacin | 125 mg 1 × daily*3 | 0.0 | ++ | + | ++ |
| Fosfomycin- trometamol | 3 g every 10 days | 0.14 | +++ | +++ | +++ |
| Postcoital single-dose prophylaxis | |||||
| Cotrimoxazole | 40/200 mg | 0.3 | +(+) | ++ | ++ |
| Cotrimoxazole | 80/400 mg | 0.0 | +(+) | ++ | ++ |
| Nitrofurantoin | 50 mg | 0.1 | +++ | +++ | ++ |
| Nitrofurantoin | 100 mg*2 | 0.1 | +++ | +++ | ++ |
| Cefalexin | 250 mg*3 | 0.0 | n.d. | + | +++ |
| Cefalexin | 125 mg*3 | 0.0 | n.d. | + | +++ |
| Norfloxacin | 200 mg*3 | 0.0 | ++ | + | ++ |
| Ofloxacin | 100 mg*3 | 0.03 | ++ | + | ++ |
*1In older studies, trimethoprim 50 mg was reported as equieffective to 100 mg; *2in the case of equieffectiveness, nitrofurantoin 50 mg is the dose of choice; *3to avoid collateral damage and above all increasing resistance; use only if the other substances cannot be used.
n.d., No data
Symbols as explained in Table 1